Real Money authors - Ed Ponsi

Ed Ponsi

Ed Ponsi is the managing director of Barchetta Capital Management, an NFA-registered commodity trading advisory, and is also the president of FXEducator. An experienced professional trader, Ponsi has advised a variety of hedge funds and institutional traders. Ponsi has appeared on CNBC more than 50 times and has been profiled in magazines such as "Technical Analysis of Stocks and Commodities" and "The Traders Journal." He is the author of Selling America Short: The New World Order vs. the American Middle Class, released in Novermber 2011; Forex Patterns and Probabilities, a top-selling book on currency trading that has been translated for release in China; and The Ed Ponsi Forex Playbook, which was endorsed by Steve Hanke, professor of applied economics at The Johns Hopkins University.
Email Ed Ponsi

Recent Articles By The Author

3 Bombshells That Rocked the Market

Between Powell and Yellen it was quite a day. And what a reaction we got.

Tempted to Buy Banks? Don't Catch a Falling Piano

How can we place an accurate value on any individual financial institution right now?

Credit Suisse Gets a Lifeline: Should Investors Buy the 'Two Buck Chuck' Bank?

The current situation is reminiscent of 2008, when Citigroup traded at about $1. Let's look how that's played out.

Banking on Fear: 3 Reasons I'm Shedding Some Weight

Here's why volatility is back, fear is good and I'm selling rallies.

Hello S&P 500 Trendline, My Old Friend

This is the key to determining if the current bull trend will continue, or is about to end.

Here's How Innovation Can Drive Apple Higher

The tech giant's stock won a buy rating from Goldman Sachs, and its work on a medical innovation could be a game-changer.

Here's How I'm Playing the Copper Rally

China consumes more copper than any country on earth, and demand for the red metal rises as its economy improves.

The S&P 500 Is at an Inflection Point: Will Bulls or Bears Gain the Upper Hand?

The winner of this struggle will assume control in the near term.

Credit Suisse and the Ghost of Lehman

Is fifteen years a long time? It all depends on your perspective.

Drug Stocks Often Trade in a Pack, but Not Now. Here Are Leaders and Laggards

Although pharmaceutical companies as a group are keeping pace with the broader market, there is considerable divergence in individual names.

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight